Twist Bioscience本社
681 Gateway Blvd
South San Francisco, CA 94080
発表者:
Oren Beske
Head of Biologics, Twist Bioscience
このウェビナーでわかること
Understand the "Lab-in-the-Loop" Framework: Learn how to seamlessly integrate computer-guided in silico design with high-throughput wet-lab testing to validate AI-generated antibody outputs in weeks rather than months.
Navigate High-Diversity Sequence Spaces: Discover how to efficiently explore vast antibody sequence spaces by either building custom variant DNA libraries or utilizing pre-validated, fully human antibody libraries.
Leverage High-Throughput Production and Analytics: Evaluate the capacity of automated platforms to handle massive screening volumes (100k+/year) while executing comprehensive analytical assessments like affinity, thermal stability, and specificity profiling.
Optimize Lead Generation Strategies: Identify the core differences and advantages of deploying distinct in vivo (e.g., hyperimmune or humanized mice) versus in vitro (e.g., phage or yeast display) discovery services for difficult therapeutic targets.
本結果は、データが取得された機関に固有のものであり、他の機関における結果を保証するものではありません。
研究用途に限り、診断目的には使用できません。
ウェビナーを視聴するために、
お客様情報をご記入ください。
お客様情報をご記入ください。
